← Leaderboards
Kaitlin Freeberg
University Of Colorado
$114,677
Attributed
$114,677
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $38.9K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$114,677 · 1
By mechanism
F31$114,677 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado
Same institution · by research overlap
- Douglas R Seals$39,040,406
- Ashley Elizabeth Walker$3,475,010
- Christopher Martens$3,611,104
- Daniel Harrison Craighead$1,111,708
- Matthew J Rossman$1,391,900
Others in their field
Other Emerging Leaders on “Aftercare”
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,888,963
- Bronwen Shaw · Medical College Of Wisconsin$19,182,557
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$13,559,983
- Ki Young Chung · Prisma Health - Upstate$8,495,983
- Deanna A Kulpa · Emory University$8,444,989
Research focus
AftercareAnimal DataAnti-Inflammatory AgentsAntiinflammatory EffectAortaArterial StiffnessArteriesBiochemicalBiochemistryBioinformaticsBiological AvailabilityBiomedical ResearchBiometryBlood PressureBlood SpecimenBurden Of IllnessCaloric RestrictionCapsuleCardiovascular DiseasesCardiovascular Disorder RiskCardiovascular HealthCardiovascular PhysiologyCareer DevelopmentAdult
Grant awards (3)
Nicotinamide Riboside Supplementation for Decreasing Inflammation in Middle-Aged and Older Adults$38,875
F31 · FY2022 · HL · contact PI
Nicotinamide Riboside Supplementation for Decreasing Inflammation in Middle-Aged and Older Adults$38,159
F31 · FY2021 · HL · contact PI
Nicotinamide Riboside Supplementation for Decreasing Inflammation in Middle-Aged and Older Adults$37,643
F31 · FY2020 · HL · contact PI